Number of employees
1-4
The FDA opened a new chapter in injectable anti-aging treatments with its July 2009 approval of the use of Sculptra®Aesthetic "for the correction of shallow to deep nasolabial fold contour deficiencies and other facial wrinkles." Sculptra®Aesthetic is composed of an injectable biocompatible material, poly-L-lactic acid, that stimulates the production of the skin's own collagen resulting in a gradual and very natural appearing restoration of facial volume and youthful facial contours. Dr.